Study shows virtual colonoscopy can improve colorectal cancer screening rates

Providing computed tomography colonography (CTC) - otherwise known as virtual colonoscopy - as an alternative to conventional colonoscopy could improve colorectal cancer (CRC) screening rates, according to a study in the November issue of the American Journal of Roentgenology (www.ajronline.org).

CRC is the second leading cause of cancer in the U.S. "While colonoscopy is currently the preferred test for CRC screening, the invasive and time-consuming characteristics of the test are often cited as reasons for noncompliance with screening," said Fouad J. Moawad, lead author of the study and physician at Walter Reed Army Medical Center in Bethesda, MD.

The study, performed at the National Naval Medical Center in Bethesda, MD, included 250 consecutive average-risk patients undergoing CRC screening who completed a survey that assessed reasons for choosing CTC in lieu of colonoscopy, compliance with CRC screening if CTC was not offered and which of the two tests they preferred.

"Had CTC not been an available option, 91 of the 250 patients would have foregone CRC screening. Among the 57 patients who had experienced both procedures, 95 percent preferred CTC," said Moawad. The most common reasons for undergoing CTC included convenience (33.6 percent), recommendation by referring provider (13.2 percent) and perceived safety (10.8 percent).

"It is recognized that screening reduces CRC incidence and mortality. Despite this widely acknowledged benefit, patient adherence to screening guidelines remains suboptimal," said Moawad.

"Our findings show the importance of providing CTC as an alternative screening option for CRC at our institution, which may increase CRC adherence screening rates," he said.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Global study reveals shifting trends in ovarian cancer incidence by subtype and region